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Abstract: Purpose. The purpose of this study was to assess primary health care providers’ knowledge and use of genetic 
services for children whose hearing screening indicates they may be deaf or hard of hearing (DHH) and identify areas in 
which health care providers can be supported to increase family education and referral of families for genetic consultation.
Methodology. A survey was developed on current practices, knowledge, and perceived beliefs regarding genetic 
education and referrals for deafness. The surveys were distributed to pediatricians, family medicine physicians, nurse 
practitioners, and physician assistants in Washington DC, Delaware, Maryland, New Jersey, New York, Pennsylvania, 
Virginia, and West Virginia.
Results. Among 266 respondents, 80% were uninformed about Early Hearing Detection Intervention (EHDI) 1-3-6 
guidelines prior to taking the survey. Approximately 55% were not confident about the genetic causes of deafness, 44% 
rarely consulted genetics professionals, 41% had not referred families to genetics, and 37% were not confident about the 
importance of genetic referrals.
Conclusions. Integrated, targeted, and user-friendly genetics education strategies in the existing EHDI framework are 
needed to ensure adequate awareness and delivery of genetics services for children who are DHH.
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Approximately 3 to 4 per 1000 infants are born each year 
in the United States whose hearing thresholds indicate 
they are moderately, severely, or profoundly deaf or hard 
of hearing (DHH; Mercer, 2015). Early Hearing Detection 
and Intervention (EHDI) systems work to ensure timely 
identification and intervention for infants and toddlers 
who are DHH and include public health surveillance of 
newborn hearing screening (NBHS). The EHDI system 
has promoted 1-3-6 guidelines, recommending newborn 
screening no later than 1 month of age, evaluation of 
those infants who do not pass their hearing screening by 
3 months of age, and enrollment in early intervention by 6 
months of age. 1-3-6 has been shown to positively impact 
speech and language development for those identified as 
DHH (Moeller, White, & Shisler, 2006). More than 95% 
of all newborns1 in the United States have their hearing 
screened at birth through NBHS with federal and state 
support (Muñoz, Shisler, Moeller, & White, 2009). 
Progress in genetics has led to the identification of multiple 
genes causing non-syndromic and syndromic impacts on 
hearing levels, with over 400 genes now identified (Toriello, 
Reardon, & Gorlin, 2004). The majority of genetic causes 
(about 70%) are non-syndromic with more than half of 
identifiable variants or gene changes in two genes, GJB2 
and GJB6. These genes are associated with moderate 
to profound bilateral, sensorineural, and non-progressive 
impacts on hearing levels (Shearer, Hildebrand, & Smith, 
2017). About 30% of children who are DHH with a genetic 
component have associated physical and clinical features 
such as retinitis pigmentosa (Usher syndrome), inner ear 
deformities and thyroid goiter (Pendred syndrome), cardiac 
arrhythmias (Jervell and Lange-Nelson syndrome), and 
renal malformations (Branchiootorenal syndrome; Shearer 
et al., 2017). The co-morbidities associated with these 
syndromes warrant additional medical assessments in 
newborns who are DHH. Previous studies have described 
how genetics evaluations can be incorporated into the 
EHDI process and benefit the parents of children with 
hearing impairment (Mercer, 2015; Muñoz et al., 2009; 
Schimmenti et al. 2004; White, 2004).
The benefits of an early genetic evaluation of newborns 
who are identified as DHH are numerous. First, a genetic 
evaluation can help families understand why their child 
is DHH, potentially reducing unnecessary concerns. 
Second, genetic evaluation can provide families with 
additional information about the services that might be 
helpful for their child and family. Given this information, 
families may consider reaching out to other families who 
have children with similar genetic backgrounds, building 
a stronger support system. Third, genetic evaluation can 
support a more thorough formation of a personalized 
medical care plan, thereby empowering families to obtain 
better care. This formation of a medical care plan can also 
provide additional connections to necessary medical and 
psychosocial support services. Further, an early genetic 
evaluation may help families better understand the  
link between hearing loss and genetics, and can  
provide an opportunity to discuss recurrence risk with 
genetic professionals.
Recent literature indicates that genetic services are 
under-utilized. A 2005 survey conducted by the National 
Center for Hearing Assessment and Management 
(NCHAM) indicated only 8.8% of physicians (n = 1,968) 
routinely refer a child who is DHH to a geneticist (Moeller 
et al., 2006). The referral rate for audiologists and 
otolaryngologists was higher, with 56% of audiologists 
reporting that they would often or always refer a hearing 
couple with one child who is DHH for genetic counseling 
(Connelly, 2010). When asked what initial set of tests 
they use in an infant with confirmed nonsyndromic 
sensorineural hearing loss, 49% of otolaryngologists 
reported they order a genetics evaluation (Duncan, 
Prucka, Wiatrak, Smith, & Robin, 2007). A simulation-
based survey found that 37% of otolaryngologists and 
geneticists ordered a genetic consultation on the first 
encounter of sensorineural hearing loss and 30% did so 
on the second encounter (Jayawardena, Shearer, & Smith, 
2015). Although physicians recognize the importance of 
genetics evaluation for children that are DHH, various 
challenges continue to persist in making physician referrals 
to genetics services. The 2005 NCHAM survey found that 
90% of physicians perceived there being somewhat of 
a need or a great need for training and/or resources on 
genetics and DHH (Moeller et al., 2006). Furthermore, 
physicians have cited lack of appropriate education 
or training to make referrals and uncertainty about the 
usefulness of genetics (Connelly, 2010).
Because of the known under-utilization of genetic services 
by primary care providers caring for individuals who are 
DHH, we sought to assess primary health care providers’ 
knowledge and use of genetic services for children who 
are DHH. We further sought to identify areas in which 
health care providers can be supported in increasing family 
education and referral of families for genetic consultation. 
The long-term goal of this study is to improve services for 
infants and children who are DHH as well as their families 
by integrating genetic services into the management of 
patients who are DHH.
Method 
Instrument
The hearing loss needs assessment was developed 
through a collaboration between the New York–Mid-
Atlantic Consortium for Genetic & Newborn Screening 
Services (NYMAC) and the National Center for Hearing 
Assessment and Management (NCHAM). NYMAC is 
one of seven regional genetics collaboratives funded 
by the Health Resources and Services Administration 
(HRSA). The region encompasses the District of 
Columbia, Delaware, Maryland, New Jersey, New York, 
Pennsylvania, Virginia, and West Virginia. Two previous 
NCHAM surveys (distributed in 2005 and 2012), 
1An updated percentage of newborns receiving hearing screening can be found at https://www.cdc.gov/ncbddd/hearingloss/ehdi-data2015.html
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literature reviews, and ongoing discussions with the 
NYMAC region EHDI coordinators and the Leadership 
Education in Neurodevelopmental and Related 
Disabilities (LEND) faculty guided the design of the 
survey. The survey was designed to identify the unmet 
needs of children, families, and professionals regarding 
use of genetics in hearing loss screening, diagnosis, 
and referral.
The 10–20 minute survey was available in paper 
and electronic format and consisted of 32 questions 
divided into four sections: (a) demographic information, 
(b) knowledge and beliefs about genetic referrals 
for children with hearing loss, (c) current practice 
regarding referrals for children with hearing loss, and 
(d) resources and strategies needed (see Appendix for 
a copy of the survey). The survey also included links 
to available resources, including the American College 
of Medical Genetics and Genomics (ACMG) Action 
Sheet on patients who are DHH and genetics. Notably, 
DHH was defined as permanent, bilateral or unilateral, 
sensorineural or conductive hearing loss of an average 
loss of 30 decibels or more in the frequency range 
important for speech recognition. 
The Johns Hopkins University and the Utah State 
University Institutional Review Boards approved the 
study.
Participants and Procedures 
EHDI coordinators in the NYMAC region were contacted 
by NCHAM with study information, the paper survey, a 
pre-addressed and stamped envelope, instructions for 
completion, and a URL to the electronic version of the 
survey. EHDI coordinators then contacted pediatricians, 
family medicine physicians, nurse practitioners, and 
physician assistants within their states to invite them 
to complete the needs assessment. Respondents 
were encouraged to share the survey link with fellow 
providers to enhance uptake. Respondents were asked 
to complete only one survey (paper or electronic). 
Contact information for NYMAC and NCHAM  
was provided. 
A follow-up email reminder to the target population 
was sent via Medical Marketing Services, Inc. (MMS), 
a professional service provider. MMS estimated that 
17,974 physicians, 4,837 advance practice nurse or 
nurse practitioners, and 1,373 physician assistants 
received the email blast. Two written reminders and 
one e-mailed reminder were sent to EHDI coordinators 
to encourage providers in their states to complete the 
needs assessment. The paper survey was re-sent to 
providers in the state of Delaware only.
Analytic Strategy
Responses to demographic questions, questions related 
to knowledge and beliefs about genetic hearing loss 
referrals, current practices for hearing loss referrals, and 
resources and strategies are reported. All comparisons 
across groups (i.e., disciplines) herein were carried out 
using chi-square tests of independence. All analyses 
were conducted using the R statistical environment 
version 3.4.2 (R Core Team, 2018).2 
Differences in the number of genetic referrals, timing of 
genetic referrals, and reasons for genetic referrals were 
examined by professional discipline. Differences in the 
perceived frequencies of challenges (not a challenge, 
sometimes a challenge, always a challenge, not 
applicable) relating to typical challenges experienced by 
clinical professionals were examined by reasons for the 
genetic referrals as well.
Results 
Sample Characteristics
A total of 266 participants across 8 states and the 
District of Columbia completed the survey. Participants 
were allowed to skip questions; therefore, the response 
rate varied per question. Table 1 presents demographic 
information regarding the participants, including their 
specialty, experience, and practice information. Of the 
respondents, 47% were pediatricians, 53% worked in 
private practice, most (68%) worked in either a large 
or small metropolitan area, and 42% had more than 20 
years of experience.
Table 1
Demographic Information about the Participants
2All code and data used in the present study are provided at: https://osf.io/8thwf
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Provider Knowledge and Beliefs
A total of 266 participants across 8 states and the 
District of Columbia completed the survey. Participants 
were allowed to skip questions; therefore, the response 
rate varied per question. Table 1 presents demographic 
information regarding the participants, including their 
specialty, experience, and practice information. Of the 
respondents, 47% were pediatricians, 53% worked in 
private practice, most (68%) worked in either a large 
or small metropolitan area, and 42% had more than 20 
years of experience.
Table 2 shows the responses regarding the participants’ 
levels of confidence in speaking with parents of a child 
with permanent hearing loss about the genetic causes 
(52% not confident), the importance of genetic referrals 
(33% not confident), the logistics of genetic referrals 
(3% not confident), and the significance of genetics in 
hearing loss due to ototoxic medication exposure (43% 
not confident).
Current Practice
Approximately 41% of the participants have referred 
a family to a genetics specialist because there was a 
family history of hearing loss, 4.3% because the parents 
Table 2 
Responses about the Confidence Level in Speaking with  
Parents of a Child with Permanent Hearing Loss about  




were discussing another pregnancy, and 3.9% because 
the parents asked for a referral. However over a third 
(37.1%) of the participants stated that they had not 
made a genetic referral. Nearly 40% of all participants 
indicated they have not consulted with a genetics 
specialist without a formal referral, with another 39% 
rarely consulting with a genetics specialist. The majority 
of participants (59%) had never ordered eConnexin 26 
testing in infants with nonsyndromic hearing loss. 
Table 3 shows the number of referrals, when referrals 
are made, and for what reason by discipline. Although 
there was a statistically significant difference of the 
reason for referral by discipline (p < .001), further 
analyses showed that physician assistants (12%), family 
medicine physicians (46%), and nurse practitioners 
(51%) were less likely to have made a referral as 
compared to pediatricians (84%; p < .001). Beyond this, 
there were no differences between disciplines regarding 
reasons for a referral (p = .435).
In addition, several participants indicated that they did 
not have tracking in place for failed newborn hearing 
screening (30%), failed newborn blood spot screening 
(26%), delayed developmental milestones (31%), and 
follow-up after referrals (32%). Of those that received 
reports of the newborn hearing screening, nearly 
80% say they sometimes or often refer children to a 
genetics referral. Notably, however, this differed by 
discipline with family medicine physicians rarely making 
a genetic referral in these situations compared to other 
professionals (p = .002).
Figure 1. Responses regarding challenges faced about the genetics of hearing loss. 
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Challenges and Opportunities
A final question was asked regarding challenges 
professionals face in respect to making genetic referrals 
for hearing loss (see Figure 1). The greatest challenge 
perceived by the survey participants when making 
genetic referrals were the parent/family priorities about 
genetic referrals (78.5% indicating always or sometimes 
a challenge) followed by the family’s inability to attend 
an appointment due to logistics, such as transportation 
or child care coverage (72.7% saying always or 
sometimes a challenge). More than half of participants 
indicated that lack of information to make the referral 
was a challenge as well. Neonatologists (83%) and 
pediatricians (65%) said lack of information/resources 
was not a challenge compared to family medicine 
physicians (11%), nurse practitioners (21%), and 
physician assistants (24%; p < .001).
A majority (84%) reported that a handout with resources 
on genetics of hearing loss for providers and families 
would be very helpful (Figure 2). Similar responses were 
given for both a quick reference guide about genetic 
referrals (82%) and contact information about genetic 
professionals in their area (74%). Educational webinars 
were far less popular with only 36.3% of participants 
indicating that webinars would be very helpful.
Figure 2. Perceived needs of the participants regarding training, information, and other resources about genetics and  
hearing loss (HL). 
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Discussion 
These results strongly support the need for education 
on genetics and patients who are DHH for primary care 
providers, as 43% of respondents indicated they lack 
information on this topic. Data from the current study 
supports a prior physician survey on congenital hearing 
loss, in which approximately 40% of respondents 
perceived a great need for training and/or resources on 
genetics and DHH (Moeller et al., 2006).
In addition to education on genetics and patients who 
are DHH, there is a need for public health surveillance 
to ensure newborns identified as DHH through hearing 
screening have a genetic evaluation. As noted in 
our results, many participants do not have tracking 
mechanisms in place for NBHS and other infant health 
processes. However, several states in the NYMAC 
region do have existing mechanisms for incorporating 
genetics into their EHDI program activities. In Virginia, 
parents are called after a newborn is identified as DHH 
to verify enrollment in early intervention services and 
the completion of the diagnostic work-up, including 
a genetics evaluation. In New Jersey, primary care 
providers are sent a checklist of necessary post-
diagnosis evaluations including genetics after 
identification. In Delaware, all newborns are referred 
to audiology at a single site, which allows for tracking 
of the post-diagnostic work-up. Going forward, HRSA-
funded EHDI programs will be held responsible for 
improving care coordination through the patient/
family-centered medical home model. Programs are 
required to report the number of care coordination 
plans developed with the parent or family and the 
number of care coordination plans that are shared 
across providers. This new, funded activity provides 
EHDI programs an opportunity to incorporate genetic 
evaluations into care plans and to include the sharing of 
care plans with the genetics provider.
Primary care provider education and public health 
surveillance are key to improving access to genetic 
services for newborns that are DHH, but based on our 
results, other barriers exist. Although we found that 
primary care providers perceive family acceptance 
as a barrier, a previous survey of parents of children 
who are DHH indicated that about 96% of parents—of 
whom none were DHH and about a quarter reported 
a family member born deaf—had a positive attitude 
toward genetic evaluation. A broader community of 
hearing, deaf, and hard-of-hearing adults supported 
genetic evaluation for newborns and expressed their 
willingness to engage in genetic counseling. Most 
families of children who are DHH value the availability of 
genetic testing as a means of better understanding the 
cause of the hearing loss and promoting discussion of 
the condition. (Geelhoed, Harrison, Davey, & Walpole, 
2009).
Response to Needs
In response to the identified need for genetics 
education, NYMAC conducted an educational campaign 
using professional marketing (Figure 3) from May 1, 
2017 through May 29, 2017. The campaign targeted 
pediatricians from New York, Delaware, Washington 
DC, Maryland, New Jersey, Pennsylvania, Virginia, and 
West Virginia. Standard desktop and tablet banners 
were placed on the American Academy of Pediatrics 
and AAP Publications websites. The campaign reached 
215,949 pediatricians. This campaign represents 
one approach to provide education on genetics and 
hearing loss, but novel methods for ongoing education 
is needed—not only for this topic, but for genetics as a 
whole. In the survey, providers indicated a preference 
for handouts (83.9%), a quick reference guide (82.4%), 
and contact information about genetic professionals 
(73.7%). Although preparation of these materials is 
straightforward, incorporating them into practice is likely 
to be more challenging.
Figure 3. Ad used for educational campaign on the effect of 
genetics on being deaf or hard of hearing in the New York–
Mid-Atlantic Consortium for Genetic & Newborn Screening 
Services Region.
Results also showed that providers perceive 
appointment logistics as a barrier to families receiving 
genetics evaluations. NYMAC is piloting several 
methods to reduce barriers related to appointment 
logistics. These methods include a phone line for 
help identifying a genetic service provider, expansion 
of telegenetics services, primary care provider 
education, and a formal relationship between primary 
care providers and a geneticist to review cases. The 
HRSA-funded Regional Genetics Networks are piloting 
different approaches to improve access to genetic 
services. Individuals with a variety of genetic conditions, 
including children who are DHH, will benefit from these 
nationwide activities.
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Notably, there are a number of limitations to the study. 
First, the survey response rate was low, with only 266 
of more than 24,000 professionals returning the survey. 
This indicates that the sampling may be biased toward 
certain groups. It is therefore difficult to assess the 
generalizability of this single sample. However, this 
may not be a major limitation given the corroboration 
between these results and prior results mentioned 
earlier. Second, there were missing values for many 
questions. For all tables, the number of participants that 
answered each question was noted.
Conclusion 
Ultimately, this study may highlight the challenges and 
needs for healthcare professionals in their work with 
children who are DHH. Results indicate that there is a 
need for integrated, targeted, and user-friendly genetics 
education strategies for providers of children who are 
DHH, to ensure adequate awareness and delivery of 
genetics services for these children. This could include 
early intervention providers, as they may be able to 
encourage families to learn more about the genetic 
evaluation process if they have not pursued this. With 
recommendations coming from multiple sources, 
parents/family members may progressively become 
more interested in understanding their child’s genetic 
background.
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Appendix 
The following is what was presented to the online surveys. The paper surveys are extremely similar in appearance.
Each year, 3 in 1,000 infants are born in the US with moderate, severe, or profound hearing loss (HL). By age 19, 15% of 
adolescents have HL in one or both ears. Newborn hearing screening (NBHS) is included in the Recommended Universal 
Screening Panel for newborns. The national and state Early Hearing Detection and Intervention (EHDI) programs funded 
by the Centers for Disease Control & Prevention (CDC) and the Maternal & Child Health Bureau (MCHB) of the Health 
Resources and Services Administration (HRSA), in cooperation with professional societies, support families of children 
with HL and their providers based on the EHDI 1-3-6 guidelines: 
• Screening by 1 month of age
• Diagnosis of HL by 3 months of age
• Entry into early intervention (EI) services by 6 months of age
 
The objectives of this research survey are to 
• Determine the unmet needs of physicians and health care providers related to genetics services for children in the 
HL screening, diagnosis, and referral continuum and 
• Identify areas where appropriate assistance can be provided to support physicians to increase family education 
about and genetic referrals for HL.
This research survey’s long-term goal is to use the findings to improve services for infants and children with HL as well as 
their families by integrating genetic services into the management of patients and families with HL.
Your completion of this survey or questionnaire will serve as your consent to be in this research study. Please take about 
10–20 minutes to tell us about your experiences. Your responses are completely confidential and will be used to improve 
services for infants and young children with hearing loss. Your participation is greatly appreciated.
























5. Year(s) of practice with pediatric population: 





More than 20 years
Hearing Screening Genetics
Hearing Loss that is permanent, bilateral or unilateral, sensorineural or conductive, and averaging loss of 30 decibels or 
more in the frequency range important for speech recognition. The following questions are about children who were identi-
fied through newborn hearing screening (NBHS) as having hearing loss.
6. Do you receive reports about children who have failed their newborn hearing screening (NBHS)?
Yes
No
7. Have you referred parents who have a child with hearing loss identified through NBHS to genetics professionals? (If 
you answered “No” to this question, you will skip to Question #11)
Yes
No














10. For infants identified through NBHS as having hearing loss, what is your best estimate of the earliest stage at which:
Parents/family need 




At the time of
enrollment in
early intervention
At the time of
screening




Other Identification and Genetics
The following questions are about children who were identified as having hearing loss via means OTHER THAN newborn 
hearing screening (NBHS). 
11. Have you referred parents who have a child with hearing loss identified through means other than NBHS to genetics 
professionals? (If you answered “No” to this question, you will skip to Q15)
Yes
No
12. If/When you have a child with hearing loss identified through means other than NBHS, how often do you refer the 






13. In the last year, approximately how many patients did you refer for genetic evaluation of hearing loss after identifica-






14. For patients identified through a means other than NBHS as having hearing loss what is your best estimate of the 
earliest stage at which:
Parents/family need 




At the time of
enrollment in
early intervention
At the time of
screening




All Children with Hearing Loss and Genetics
The following questions are about ALL children with hearing loss, regardless of how they were identified.
15. Which is the primary reason why you refer families to a genetics professional for hearing loss?
Parents ask for a referral
There is a family history of hearing loss
Parents are discussing another pregnancy
I have not referred to a genetics professional for hearing loss
Other____________________________________________
16. How often do you consult with (i.e., do not make a formal referral) geneticists and genetic counselors  







17. What challenges have you experienced when referring parents/families for a genetic evaluation of the infant/child?
Lack of information/ 












Lack of family support
Transient families
Parents/families may not 
consider genetic referral 
a priority
Lack of local genetics 
provider
Lack of telehealth options
Other
Other _______________________________________________________


















19. For parents/families who already have a diagnosis of hearing loss, do  you discuss with them the genetics of  





20. It is possible that infants with nonsydromic hearing loss have indentifiable gene changes in Connexin 26 and/or 30 
(GJB2/GJB6). At what age (in months) do you thing connexin testing should be offered in a failed newborn hearing screen 
workup when there are not dysmorphic features/anomalies or a known genetic condition?
Age (in months)  ___________________________________________
Don’t think connexin testing should be ordered
Don’t know/not familiar


















I don’t knowNo Yes Not Applicable




Preauthorization for HL 
genetic testing
Follow up after referrals





25. How informed do you think you are about...
The genetics of HL
The importance of  
genetic referrals
Somewhat InformedUninformed Very Informed
26. Do you have a designated system (i.e., person or computer system/database) for tracking...
Genetic causes of HL
The importance of ge-
netic referrals
The logistics of genetic 
referral for HL
The significance of 
genetics in HL due to 
ototoxic medication 
exposure
Somewhat InformedUninformed Very Informed
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29. Would you implement the following strategies to faciliate (or ensure) tracking of genetic referrals?
Implement a system to follow up with 
patients and families
Yes No
Engage case managers in the  
EHDI programs
Increase genetics education efforts




30. Have you used the following strategies to facilitate (or ensure) tracking of genetics referrals?
Implement a system to follow up with 
patients and families
Yes No
Engage case managers in the  
EHDI programs
Increase genetics education efforts





31. If you have used the following strategies to facilitate (or ensure) tracking of genetic referrals did it work?
Implement a system to 
follow up with patients 
and families
Engage case managers 
in the EHDI programs
YesNo Somewhat Have Not Used
Increase genetics edu-
cation efforts
Implement a system 




32. Would you implement the following strategies to enhance collaborations and communication with EHDI/EI programs 
and primary care providers regarding genetic referrals and follow-up?
Genetics of HL Reference guide
No Yes
Handout of HL genetic testing
List of available resources on  
HL genetics
State/district-specific contact  





33. Have you used the following strategies to enhance collaboration and communication with EHDI/EI programs and pri-
mary care providers regarding genetic referrals and follow-up?
Genetics of HL Reference guide
No Yes
Handout of HL genetic testing
List of available resources on  
HL genetics
State/district-specific contact  




34. If you have used the following strategies to enhance collaboration and communication with EHID/EI programs and 
primary care providers regarding genetic referrals and follow-up, did it work?
Genetics of HL refer-
ence guide
Handout of HL genetics 
testing
YesNo Somewhat Have Not Used
List of available resourc-
es on HL genetics
State/district-specific 
contact information on 
EHDI programs and 
genetics centers
Other
Other _______________________________________________________
